Topic: Mrna Pipeline

1 chapters across the catalog

The survey's findings on the 36-50 age group dovetail with Edward Dowd's analysis of insurance death and disability data. Haviland warns that pharmaceutical companies like Moderna have approximately 40 new mRNA products in the pipeline, including shots for shingles, RSV, and the flu. He argues that the regulatory system has been "blown up" to allow these products to reach billions of people without traditional review.